Adrian Wild Named to Allurion’s Senior Management Team

Allurion Technologies Inc. has appointed Adrian Wild as senior vice president, International Commercial. Fitting to his title, Wild will lead international commercial sales and operations functions.
 
“We are thrilled to welcome Adrian to Allurion and add his expertise to our leadership team as we advance the company toward profitability,” Allurion Founder/CEO Dr. Shantanu Gaur said. “Adrian joins us at an extremely important time—where the obesity market is expanding by the day and presenting Allurion new opportunities for growth. Adrian’s expertise in building sustainable commercial organizations will be vital to our long-term success plans.”
 
Wild brings to his new position a wealth of experience in driving business growth and operational excellence across global markets. For more than a decade, he held leadership roles at Align Technology, where he contributed to establishing a new standard of care and managed the company’s European expansion to become an international market leader. Before joining Allurion, Wild was senior vice president and head of Western Europe at Straumann Group, a global developer of dental implants and orthodontic solutions, where he helped achieve significant growth through strategic marketing and operational initiatives. Prior to Straumann, Wild worked as vice president, Commercial Excellence, Global, at Mölnlycke Health Care, a global medical technology company specializing in wound care and surgical solutions. He helped improve commercial effectiveness across more than 100 countries at Mölnlycke Health Care.

“This is a great time to join Allurion as it enters a new stage of growth and development in an ever-expanding market,” Wild stated. “I look forward to working with the talented team at Allurion to capitalize on this opportunity and take the company’s commercial organization to new heights.”
 
Allurion is dedicated to ending obesity. The Allurion Program is a weight loss platform that features the Allurion Gastric Balloon, the world’s first and only swallowable, procedure-less intragastric balloon for weight loss, and offers access to the Allurion Virtual Care Suite, including the Allurion Mobile App for consumers; Allurion Insights for healthcare providers featuring the Coach Iris AI Platform; and the Allurion Connected Scale. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor, and manage weight loss therapy for patients regardless of their treatment plan: gastric balloon, surgical, medical or nutritional. The Allurion Gastric Balloon is an investigational device in the United States.